nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.02	0.02	CcSEcCtD
Agomelatine—Mania—Methylprednisolone—ankylosing spondylitis	0.0193	0.0193	CcSEcCtD
Agomelatine—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.0182	0.0182	CcSEcCtD
Agomelatine—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.0182	0.0182	CcSEcCtD
Agomelatine—Mania—Betamethasone—ankylosing spondylitis	0.0175	0.0175	CcSEcCtD
Agomelatine—Mania—Dexamethasone—ankylosing spondylitis	0.0175	0.0175	CcSEcCtD
Agomelatine—Rash erythematous—Betamethasone—ankylosing spondylitis	0.0166	0.0166	CcSEcCtD
Agomelatine—Rash erythematous—Dexamethasone—ankylosing spondylitis	0.0166	0.0166	CcSEcCtD
Agomelatine—Suicidal ideation—Prednisone—ankylosing spondylitis	0.0158	0.0158	CcSEcCtD
Agomelatine—Mania—Prednisone—ankylosing spondylitis	0.0153	0.0153	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Agomelatine—Irritability—Methylprednisolone—ankylosing spondylitis	0.00971	0.00971	CcSEcCtD
Agomelatine—Migraine—Dexamethasone—ankylosing spondylitis	0.0091	0.0091	CcSEcCtD
Agomelatine—Migraine—Betamethasone—ankylosing spondylitis	0.0091	0.0091	CcSEcCtD
Agomelatine—Irritability—Dexamethasone—ankylosing spondylitis	0.00883	0.00883	CcSEcCtD
Agomelatine—Irritability—Betamethasone—ankylosing spondylitis	0.00883	0.00883	CcSEcCtD
Agomelatine—Influenza—Triamcinolone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Agomelatine—Weight increased—Prednisolone—ankylosing spondylitis	0.00872	0.00872	CcSEcCtD
Agomelatine—Weight increased—Triamcinolone—ankylosing spondylitis	0.00802	0.00802	CcSEcCtD
Agomelatine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Agomelatine—Infestation—Methylprednisolone—ankylosing spondylitis	0.00784	0.00784	CcSEcCtD
Agomelatine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00784	0.00784	CcSEcCtD
Agomelatine—Face oedema—Prednisone—ankylosing spondylitis	0.00777	0.00777	CcSEcCtD
Agomelatine—Irritability—Prednisone—ankylosing spondylitis	0.00769	0.00769	CcSEcCtD
Agomelatine—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00749	0.00749	CcSEcCtD
Agomelatine—Weight increased—Betamethasone—ankylosing spondylitis	0.00727	0.00727	CcSEcCtD
Agomelatine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00727	0.00727	CcSEcCtD
Agomelatine—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00723	0.00723	CcSEcCtD
Agomelatine—Weight decreased—Betamethasone—ankylosing spondylitis	0.00723	0.00723	CcSEcCtD
Agomelatine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.007	0.007	CcSEcCtD
Agomelatine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00691	0.00691	CcSEcCtD
Agomelatine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Agomelatine—Irritability—Methotrexate—ankylosing spondylitis	0.00642	0.00642	CcSEcCtD
Agomelatine—Hallucination—Betamethasone—ankylosing spondylitis	0.00637	0.00637	CcSEcCtD
Agomelatine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00637	0.00637	CcSEcCtD
Agomelatine—Weight increased—Prednisone—ankylosing spondylitis	0.00633	0.00633	CcSEcCtD
Agomelatine—Weight decreased—Prednisone—ankylosing spondylitis	0.0063	0.0063	CcSEcCtD
Agomelatine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Agomelatine—Depression—Prednisone—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Agomelatine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Agomelatine—Angioedema—Prednisolone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Agomelatine—Vertigo—Prednisolone—ankylosing spondylitis	0.006	0.006	CcSEcCtD
Agomelatine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Agomelatine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Agomelatine—Back pain—Triamcinolone—ankylosing spondylitis	0.00594	0.00594	CcSEcCtD
Agomelatine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Agomelatine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Agomelatine—Hallucination—Prednisone—ankylosing spondylitis	0.00554	0.00554	CcSEcCtD
Agomelatine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00551	0.00551	CcSEcCtD
Agomelatine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0055	0.0055	CcSEcCtD
Agomelatine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Agomelatine—Eye disorder—Prednisone—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Agomelatine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.0052	0.0052	CcSEcCtD
Agomelatine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Agomelatine—Infestation—Methotrexate—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Agomelatine—Depression—Methotrexate—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Agomelatine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Agomelatine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00509	0.00509	CcSEcCtD
Agomelatine—Angioedema—Betamethasone—ankylosing spondylitis	0.00509	0.00509	CcSEcCtD
Agomelatine—Vertigo—Dexamethasone—ankylosing spondylitis	0.005	0.005	CcSEcCtD
Agomelatine—Vertigo—Betamethasone—ankylosing spondylitis	0.005	0.005	CcSEcCtD
Agomelatine—Infection—Triamcinolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Agomelatine—Infection—Methylprednisolone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Agomelatine—Insomnia—Prednisolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Agomelatine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Agomelatine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Agomelatine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Agomelatine—Mental disorder—Prednisone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Agomelatine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Agomelatine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Agomelatine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Agomelatine—Anxiety—Betamethasone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Agomelatine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Agomelatine—Hepatitis—Methotrexate—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Agomelatine—Vision blurred—Prednisone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Agomelatine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Agomelatine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Agomelatine—Infection—Betamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Agomelatine—Infection—Dexamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Agomelatine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Agomelatine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Agomelatine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Agomelatine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Agomelatine—Agitation—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Agomelatine—Angioedema—Prednisone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Agomelatine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Agomelatine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Agomelatine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Agomelatine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Agomelatine—Vertigo—Prednisone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Agomelatine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Agomelatine—Tinnitus—Methotrexate—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Agomelatine—Urticaria—Prednisolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Agomelatine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Agomelatine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Agomelatine—Anxiety—Prednisone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Agomelatine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Agomelatine—Insomnia—Betamethasone—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Agomelatine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Agomelatine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Agomelatine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Agomelatine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Agomelatine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Agomelatine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Agomelatine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Agomelatine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Agomelatine—Infection—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Agomelatine—Back pain—Methotrexate—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Agomelatine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Agomelatine—Fatigue—Betamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Agomelatine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Agomelatine—Skin disorder—Prednisone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Agomelatine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Agomelatine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Agomelatine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Agomelatine—Vertigo—Methotrexate—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Agomelatine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Agomelatine—Urticaria—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Agomelatine—Dizziness—Prednisolone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Agomelatine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Agomelatine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Agomelatine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Agomelatine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Agomelatine—Insomnia—Prednisone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Agomelatine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Agomelatine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Agomelatine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Agomelatine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Agomelatine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Agomelatine—Fatigue—Prednisone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Agomelatine—Headache—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Agomelatine—Constipation—Prednisone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Agomelatine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Agomelatine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Agomelatine—Infection—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Agomelatine—Asthenia—Betamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Agomelatine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Agomelatine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Agomelatine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Agomelatine—Nausea—Prednisolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Agomelatine—Pruritus—Betamethasone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Agomelatine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Agomelatine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Agomelatine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Agomelatine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Agomelatine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Agomelatine—Urticaria—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Agomelatine—Headache—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Agomelatine—Headache—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Agomelatine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Agomelatine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Agomelatine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Agomelatine—Dizziness—Betamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Agomelatine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Agomelatine—Insomnia—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Agomelatine—Nausea—Triamcinolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Agomelatine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Agomelatine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Agomelatine—Somnolence—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Agomelatine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Agomelatine—Vomiting—Betamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Agomelatine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Agomelatine—Fatigue—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Agomelatine—Headache—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Agomelatine—Headache—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Agomelatine—Asthenia—Prednisone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Agomelatine—Pruritus—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Agomelatine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Agomelatine—Nausea—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Agomelatine—Nausea—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Agomelatine—Urticaria—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Agomelatine—Dizziness—Prednisone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Agomelatine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Agomelatine—Vomiting—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Agomelatine—Headache—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Agomelatine—Asthenia—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Agomelatine—Nausea—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Agomelatine—Pruritus—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Agomelatine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Agomelatine—Dizziness—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Agomelatine—Vomiting—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Agomelatine—Headache—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Agomelatine—Nausea—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
